2016 Launched PegberonTM (Peginterferon alfa 2b), National Class I New Drug
2013Awarded as National Innovation Team in Priority Areas by MOST
2012 Awarded as the Major High-Tech Enterprise in National Torch Plan
2012 Approved as National-local Joint Research Center for Recombinant Protein Drugs
2011Awarded as National Innovation-oriented Enterprise
2010Undertook demonstration project for national high-tech industrialization
2009 Undertook several major national projects for research and development of new biological drugs.
2009 Took part in establishment of its first oversea plant for biological drugs.
2008 Established a post-doctoral workstation in Amoytop Biotech.
2006 Established Xiamen Biomedical Incubator, the major scientific and technical platform of Xiamen.
2005 Commercialized TOPMEGATM (rHuIL-11) in China.
2005 Entrusted by NICPBP to carry out the research and development work on national reference standards of seven recombinant protein products.
2004 Undertook the Pilot Project of Industrialization and Internationalization of Genetically Engineered Protein Drugs for National Development and Reform Committee, China.
2002 EstablishedBiosteed Gene Expression Tech. Co., Ltd.as its branch for research and development.
1999 Commercialized TOPNEUTERTM (rHuG-CSF) in China.
1997 Commercialized TOPLEUCONTM (rHuGM-CSF) in China, as the first domestic GM-CSF, afterward it was awarded the Key National Torch Project.
1996 Founded XIAMEN 美高梅官网注册 - 官方授权 CO., LTD.